{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRRK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Leucine-rich repeat kinase 2 (LRRK2) mutations are linked to parkinsonian symptoms, and the study investigates how these mutations affect cell viability under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that LRRK2 mutations impact cell viability and oxidative stress tolerance, which is relevant to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell viability assays under H2O2-induced oxidative stress were used to assess the impact of LRRK2 mutants.",
          "judgment": "Yes",
          "reasoning": "The cell viability assay directly models the disease mechanism by evaluating oxidative stress tolerance, which is relevant to parkinsonian symptoms."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Wild-type LRRK2 enhances stress tolerance in HEK293 and SH-SY5Y cells, while mutants (e.g., Y1699C) reduce viability under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type vs. mutants) were used, but no explicit mention of statistical replicates or variant controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Y1699C mutant shows reduced cell viability under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The functional data supports a pathogenic role for Y1699C, but no statistical analysis or OddsPath calculation is provided."
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Leucine-rich repeat kinase 2 (LRRK2) mutations are linked to parkinsonian symptoms, and the study investigates how these mutations affect cell viability under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that LRRK2 mutations impact cell viability and oxidative stress tolerance, which is relevant to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell viability assays under H2O2-induced oxidative stress were used to assess the impact of LRRK2 mutants.",
          "judgment": "Yes",
          "reasoning": "The cell viability assay directly models the disease mechanism by evaluating oxidative stress tolerance, which is relevant to parkinsonian symptoms."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Wild-type LRRK2 enhances stress tolerance in HEK293 and SH-SY5Y cells, while mutants (e.g., G2019S) reduce viability under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type vs. mutants) were used, but no explicit mention of statistical replicates or variant controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "G2019S mutant shows reduced cell viability under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The functional data supports a pathogenic role for G2019S, but no statistical analysis or OddsPath calculation is provided."
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "R",
          "alt": "C",
          "position": "1441"
        },
        "variant_string_id": "LRRK2 R1441C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Leucine-rich repeat kinase 2 (LRRK2) mutations are linked to parkinsonian symptoms, and the study investigates how these mutations affect cell viability under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that LRRK2 mutations impact cell viability and oxidative stress tolerance, which is relevant to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell viability assays under H2O2-induced oxidative stress were used to assess the impact of LRRK2 mutants.",
          "judgment": "Yes",
          "reasoning": "The cell viability assay directly models the disease mechanism by evaluating oxidative stress tolerance, which is relevant to parkinsonian symptoms."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Wild-type LRRK2 enhances stress tolerance in HEK293 and SH-SY5Y cells, while mutants (e.g., R1441C) reduce viability under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type vs. mutants) were used, but no explicit mention of statistical replicates or variant controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "R1441C mutant shows reduced cell viability under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The functional data supports a pathogenic role for R1441C, but no statistical analysis or OddsPath calculation is provided."
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    },
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Leucine-rich repeat kinase 2 (LRRK2) mutations are linked to parkinsonian symptoms, and the study investigates how these mutations affect cell viability under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines that LRRK2 mutations impact cell viability and oxidative stress tolerance, which is relevant to the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "Cell viability assays under H2O2-induced oxidative stress were used to assess the impact of LRRK2 mutants.",
          "judgment": "Yes",
          "reasoning": "The cell viability assay directly models the disease mechanism by evaluating oxidative stress tolerance, which is relevant to parkinsonian symptoms."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Wild-type LRRK2 enhances stress tolerance in HEK293 and SH-SY5Y cells, while mutants (e.g., I2020T) reduce viability under oxidative stress.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type vs. mutants) were used, but no explicit mention of statistical replicates or variant controls."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "I2020T mutant shows reduced cell viability under oxidative stress compared to wild-type.",
          "judgment": "Yes",
          "reasoning": "The functional data supports a pathogenic role for I2020T, but no statistical analysis or OddsPath calculation is provided."
        }
      ],
      "functional_evidence_strength": "PS3_supporting"
    }
  ]
}